LGALS3 and Parkinson disease: Beyond PD, recent studies show that Apoe controls the microglial transition from a healthy cell to a toxic neurodegenerative cell through regulating Lgals3 suggesting that inhibition of Lgals3 is a neuroprotective strategy for treating glaucoma86,87– highlighting it as a potential therapeutic target.